Respiratory physician Lutz Beckert considers chronic obstructive pulmonary disease management, including the prevention of COPD, the importance of smoking cessation and pulmonary rehabilitation, and the lifesaving potential of addressing treatable traits. He also discusses the logic of inhaler therapy, moving from single therapy to dual and triple therapy when indicated, as well as other aspects of management
Codeine reclassification commences 5 November
Codeine reclassification commences 5 November

Codeine-containing medicines will only be available with a prescription from today1.
Medsafe, New Zealand’s Medicines and Medical Devices Safety Authority, made the recommendation in an to attempt to:
• lower the rates of misuse of codeine,
• prevent people becoming dependant, and
• reduce the number of overdose deaths linked to the addictive drug when not taken as directed1.
Kiwis looking to manage strong pain relief without a prescription can access Nuromol from their local pharmacy or supermarket.
For more information, visit the Medsafe website.
1 Medsafe, Classification of Codeine, June 2019: https://www.medsafe.govt.nz/profs/class/Agendas/Agen63/MCC63_53a_Reclassificationofcodeine.pdf